Kayden joined J A Kemp in 2021 and is based in the Oxford office. His work covers a range of fields, including antibodies and stem cell therapies.
Before joining the firm, Kayden studied Natural Sciences at the University of Cambridge, where he obtained the highest overall mark in his cohort at the end of his BA degree. Kayden then pursued an MSci degree, during which he investigated the contribution of viral RNA sequences and structures to coronavirus assembly. He presented this research at the Microbiology Annual Conference.
During his studies, Kayden undertook various research projects in the UK, Peru and Japan, gaining experience in areas such as filopodia biogenesis and porcine nutrition. As a former Amgen Scholar, he tested the efficacy of a small-molecule drug as an anti-diabetic agent and presented his findings at symposia held at the University of Tokyo and National University of Singapore.
Kayden is a member of the firm’s diversity and inclusion group. He has worked with a charity for many years to support northern state school students in developing their social and academic confidence.